Biotain Pharma|Sitemap|Contact us|Inquiry Online Chinese German Japanese Korean Arabic Russian

Biotain Pharma


Welcome to Biotain Pharma

BIOTAIN PHARMA CO.LTD is located in Xiamen, Fujian in China. We are professional engaged in active pharmaceutical ingredients, pharmaceutical intermediates research and production. Which is a high-tech enterprise with best quality products and professional services from production to sales.

Founded in 2005, the company has established the good Corporate Structure, including R&D, production, QA, and other departments, Owned more than 300 staffs. Including more than 30 professional technical personnel, R & D team 8 people, The company covers an area of 40000 square meters. There are 8 synthesis workshop covers an area of 30000 square meters. Concerning to QC test, we have equiped with different types of analytical instruments, which can meet different test requirement. Have many sets of advanced testing equipment, such as high-pressure liquid chromatograph, gas chromatograph, ultraviolet spectrophotometer, high sensitivity of the instruments to effective analysis and monitoring products.

Research and Development

Manufacturing and Quality

Strategy and Cooperation


Contact Us

  • Biotain Pharma Co., Ltd.
  • Tel: +86 (1355 9279 514)
  • Fax: +86 592 523 6275
  • Email:
  • Work Time ( GMT+8 ):
  •    9 am - 6 PM Monday - Friday

Recent News

  • 30 June 2014:

    26-29 June 2014, the Fourteenth CPhI China exhibition held in Shanghai New International Exhibition Centre. Congratulations BIOTAIN "CPHI SHANGHAI 2014" exhibition a great success.

  • 28 February 2014:

    BIOTAIN cooperation with Jiangsu and Shandong several veterinary companies. Veterinary raw materials will be our focus of our next two years.

  • May 10, 2013:

    After Business deliberations. For the needs of the development of the international trade business, Biotain Pharma will set up branches in some countries.

  • April 10, 2013:

    In the first quarter of 2013, we completed the early 2013's international trade development plan, and increased by 12% in the first quarter of 2012.